Yiheng Capital Management, L.P. Ocugen, Inc. Call Options Transaction History
Yiheng Capital Management, L.P.
- $1.02 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
113Shares Held
72MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$16.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$5.93 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.37 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.15 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $217M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...